Skip to the main content.
Request a Quote

Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio. Read the Press Release

At Fluxion, we’re passionate about delivering cell-based solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Latest News

and Press Releases

LATEST NEWS

LATEST BLOG

Inequality of Research Funding is a Serious Problem

We are all increasingly conscious of the disparities with regard to opportunities for advancement in science between different ethnic groups and genders. Much is, rightly, being done to rectify this problem, although much more remains to be done. Meanwhile, there has been rather less concern about the vast inequalities in research funding between different countries and regions across the globe. It is clear that the global research effort is currently heavily concentrated in a relatively small...

2 min read
Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio

Positions the Company as a new leader in providing solutions that bridge the gap between cellular electrophysiology and advanced analysis techniques

August 23, 2023 – Cell Microsystems, a provider of pioneering solutions for cell biology research, is excited to announce the acquisition of Fluxion Biosciences, a leader in automated patch clamp technology and cell-based assay tools. This acquisition complements the Company’s platforms and applications based on the CellRaft technology, enhancing...

2 min read
FLUXION BIOSCIENCES EXPANDS ADVANCED THERAPEUTICS DISCOVERY SERVICES UNIT

Relocation and expansion to support high customer demand globally

October 5, 2022, Alameda, CA: Fluxion Biosciences, a privately held drug discovery and diagnostic tools and services company, announced today that it is expanding its Advanced Therapeutics Discovery Services business unit to support growing demand for assay support of the company’s unique cell analysis platforms. Growth will be supported by increasing lab staff and relocating to a new, larger laboratory. Fluxion offers a range...

2 min read
FLUXION LAUNCHES A FULLY PACKAGED ION CHANNEL SCREENING SOLUTION

A complete system for lead-to-answer screening in ion channel assays

Alameda, CA - Fluxion Biosciences, a global leader in automated patch clamp systems for ion channel drug discovery, today announced the release of an integrated and affordable solution for simplifying automated ion channel assays.

Ion channels are the third most significant drug target, after kinases and GPCRs. However, ion channels remain an underserved target class due to the significant challenges in screening and drug...

1 min read
BIOFLUX SYSTEM USED IN KEY STUDIES TO IDENTIFY CAUSES AND TREATMENTS OF BLOOD CLOTS RELATED TO COVID-19

Potential treatments identified that may offer improved outcomes in COVID-19 patients with increased thrombus formation

Alameda, Calif. -- Fluxion Biosciences announced two recent publications on COVID-19 and its ability to lead to high levels of platelet coagulation and an increased risk of thrombosis. The first study, published by a team at the University of Pennsylvania School of Medicine, was published in May 2021 as a preprint in bioRxiv, and is titled “Signaling through FcgRIIA and the...

1 min read
LARGE-SCALE LUNG CANCER CLINICAL STUDY DEMONSTRATES ACCURACY AND SENSITIVITY OF FLUXION'S ERASE-SEQ LIQUID BIOPSY

356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR

Alameda, CA, June 16, 2021 - Fluxion Biosciences announced the publication of a paper on ERASE-Seq™ liquid biopsy with molecular amplification pools (MAPs). The paper, "Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools", published in Nature Scientific Reports on May 24, is co-authored by researchers at Fluxion and the Hospices Civils de...

1 min read
FLUXION LAUNCHES BIOFLUX ONE, THE AFFORDABLE SYSTEM FOR CELL ANALYSIS UNDER LIVE SHEAR FLOW

All the benefits of the industry leading BioFlux cell analysis platform, now in a configuration every lab can afford.

Alameda, CA - Fluxion Biosciences, the leading developer of live cell analysis systems that feature physiological shear flow, has just announced the release of BioFlux One, its most affordable BioFlux system. 

The BioFlux One system is the solution for labs that run flow cell experiments but don't need 2-phase flow. It provides all the benefits of the industry standard BioFlux...

1 min read
FLUXION INTRODUCES NEW PLATE FORMAT FOR TESTING CUSTOM SUBSTRATES

New plate format allows users to test bacterial growth on a variety of substrates

Alameda, CA, January 10, 2019 - Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has launched a new BioFlux plate format that allows users to test custom substrates.

A promising approach to preventing bacterial colony formation on medical devices is the use of surfaces that are resistant to bacterial...

1 min read
Fluxion Biosciences Launches New BioFlux Plate for Studying Catheter Infections

New plate format utilizes silicone rubber construction to allow detailed study of indwelling catheter bacterial biofilms

San Francisco, CA, December 14, 2017 - Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has launched a new BioFlux plate for studying infections caused by the long-term use of catheters. The new plates are available immediately.

Silicone rubbers such as PDMS...

1 min read
BIOFLUX EXPANDS COMPATIBILITY TO AUTOMATED EVOS FL AUTO CELL IMAGING SYSTEMS

December 7, 2016

Fluxion Biosciences has introduced a new interface expanding the compatibility of their BioFlux quick release microfluidic interface to the Invitrogen™ EVOS™ FL Auto System from Thermo Fisher Scientific. The quick release interface enhances throughput and ease of use by reducing microfluidic plate mounting times. This type of interface is custom-fitted to the automated microscopy stage, and offers the best in compatibility by accepting all BioFlux well plate microfluidic...

1 min read
Fluxion announces the launch of IonFlux Mercury, its next generation automated patch clamp system.

2016-11-3South San Francisco, Calif. – Fluxion Biosciences announced today the release of a second generation of its IonFlux automated patch clamp family of products.  IonFlux Mercury will  replace and update the existing IonFlux product family. While IonFlux systems were previously  distributed by Molecular Devices, the new product line will be sold direct by Fluxion Biosciences and its partners.

IonFlux systems are being used all over the world in industry and academic laboratories and are well...

1 min read
Fluxion announced the use of its IonFlux automated patch clamp system in a successful drug discovery workflow targeting modulation of glycine receptors

August 3 2016

South San Francisco, Calif. – Fluxion Biosciences announced the release of a user publication demonstrating the efficacy of the IonFlux HT automated patch clamp system as a key component of the drug discovery process. Neusentis (Pfizer Ltd.) published a study investigating the effectiveness of discovering positive allosteric modulators (PAMs) of glycine receptors. The publication highlighted the use of a discovery workflow using a fluorescent membrane potential primary screen,...

Announcing IonFlux 16 Classic

A fully automated and affordable alternative to manual patch clamp

[ MORE INFORMATION ]

class=" image-block-outer-wrapper layout-caption-below design-layout-inline

" data-test="image-block-inline-outer-wrapper" >

class=" sqs-block-image-figure intrinsic

" style=" max-width:231px;

" >

class=" sqs-block-image-link

" href="/s/IF-C-Handout-Rev-A.pdf"

>

1 min read
Happy Holidays

The IonFlux system's unique capabilities allow for the execution of otherwise very difficult assays. Its distinctive characteristics with fast in-plate solution exchange, continuous flow of external buffers, and best-in-class temperature control, permit not only fast screening of ion channel activity but also non-traditional assays such as analysis of cell membrane conductivity in the presence of external stressors. Below are some examples demonstrating the range of flexibility IonFlux systems...

1 min read
FLUXION AND ETALUMA ANNOUNCE INTEGRATION OF BIOFLUX WITH THE LUMASCOPE

October 15, 2015

Integration combines benefits of BioFlux physiological cell interaction analysis with the compactness of the Etaluma Lumascope

August 13, 2015 – (South San Francisco, CA) Today Fluxion Biosciences and Etaluma announced a co-marketing agreement between the two companies. The agreement joins the power of Fluxion’s Bioflux System for cellular assays with Etaluma’s next generation Lumascope inverted microscopes, in applications where space limitations are of importance. Together,...

1 min read
GOLDEN HELIX AND FLUXION BIOSCIENCES JOIN IN A GLOBAL, VALUE-ADDED RESELLER AGREEMENT

February 20, 2015

Bozeman, MT (February 16, 2015) — Golden Helix, Inc. and Fluxion Biosciences, Inc. announced their collaboration in a value-added reseller relationship today, focused on the VarSeq software application for next-generation sequencing (NGS) analysis.

"Providing our global client base with a method to study tumor DNA in the circulation is a capability we are proud to offer", said Jeff Jensen, CEO of Fluxion. "Offering the VarSeq software to our customers is a critical step toward...

2 min read
FLUXION LAUNCHES HIGH THROUGHPUT QUATTRO ARRAY FOR BIOFLUX™

October 15, 2013

QUATTRO INCREASES THROUGHPUT 4X, ENABLES HCS ENDPOINT READOUT

South San Francisco, Calif., October 15, 2013 -- Fluxion Biosciences announced today that it has launched its BioFlux Quattro High Throughput Array System for physiologically relevant live cell analysis. The system is now commercially available and shipping to customers.

The Quattro Array system is sold as a separate component and can expand the capabilities of any existing BioFlux 200 or BioFlux 1000/1000z system....

4 min read
Should You Build Your Own Shear Flow System? Advantages and Disadvantages of DIY Flow Systems

Mechanical forces have been shown to impact cell phenotype and function in vivo1. The most prolific of these forces is shear stress, induced by...

3 min read
Mitigate contamination issues of shear flow experiments

See how Dr. Belleannée addressed contamination concerns in her laboratory

The BioFlux system is a game-changer in the world of experimental research....

2 min read
Models show a decrease in breast cancer metastasis when ion channels are modulated.

Existing pre-approved FDA drugs targeting potassium channels may help in Cancer treatment

Electrical voltage patterns in healthy cells serve as a...

5 min read
Emerging Immunotherapies Are Revolutionizing Cancer and Immune Disease Treatment

Exciting New T Cell Therapies Present Unique Challenges in Drug Development.

Immunotherapeutics stimulate the patient's immune system to help...

3 min read
The Many Modulators of Sleep

As we go through our lives, we spend a third of that time sleeping. Although this time does not amass to anything consciously productive, it is a...